Resources
Resources, News & MoreFeatured Resources
Helpful resources from reputable nonprofit organizations:
➜ American Heart Association: Recurrent Pericarditis Podcast Series
➜ NORD: Rare Database- Recurrent Pericarditis
➜ Myocarditis Foundation- Pericarditis
➜ French Association for Myocarditis and Pericarditis (AFMP)
Pericarditis and Autoinflammation: A Clinical and Genetic Analysis of Patients With Idiopathic Recurrent Pericarditis
Pericarditis Alliance May 25, 2022 Q&A Event
May 26, 2022 | Education, In The News, News, Resources, Webinar
Pericarditis Alliance May 25, 2022 Q&A Event
Cardiol Therapeutics Announces FDA Investigational New Drug Application…
May 18, 2022 | Press Release, Resources, Treatment
Olympic Coach Dawn Staley’s Personal Battle with Pericarditis
Kiniksa Announces FDA Approval of Arcalyst
Aug 14, 2021 | Press Release, Resources, Treatment
US DATABASE STUDY OF CLINICAL BURDEN AND UNMET NEED IN RECURRENT PERICARDITIS
THE AUTOINFLAMMATORY SIDE OF RECURRENT PERICARDITIS: ENLIGHTENING THE PATHOGENESIS FOR A MORE RATIONAL TREATMENT
KINIKSA ANNOUNCES FDA APPROVAL OF ARCALYST ® (RILONACEPT) FOR RECURRENT PERICARDITIS
Mar 18, 2021 | Press Release, Resources, Treatment
PHASE 3 TRIAL OF INTERLEUKIN-1 TRAP RILONACEPT IN RECURRENT PERICARDITIS

Real Life Stories- Pericarditis Patient: Rachel
February 11, 2022 | Article, Education, Patient Story

Dr. Allan Klein on the Cardiac Consult podcast
January 11, 2022 | Education, In The News, News, Podcast

Dona Winnowski on Community RadioExchange
December 31, 2021 | Education, In The News, News, Podcast

Olympic Coach Dawn Staley’s Personal Battle with Pericarditis

Kiniksa Announces FDA Approval of Arcalyst
August 14, 2021 | Press Release, Resources, Treatment

US DATABASE STUDY OF CLINICAL BURDEN AND UNMET NEED IN RECURRENT PERICARDITIS

THE AUTOINFLAMMATORY SIDE OF RECURRENT PERICARDITIS: ENLIGHTENING THE PATHOGENESIS FOR A MORE RATIONAL TREATMENT

KINIKSA ANNOUNCES FDA APPROVAL OF ARCALYST ® (RILONACEPT) FOR RECURRENT PERICARDITIS
March 18, 2021 | Press Release, Resources, Treatment

PHASE 3 TRIAL OF INTERLEUKIN-1 TRAP RILONACEPT IN RECURRENT PERICARDITIS

RILONACEPT PREVENTS RECURRENT PERICARDITIS: RHAPSODY

IMAGING-GUIDED THERAPIES FOR PERICARDIAL DISEASES





